SCHEMBL1768648

SCHEMBL1768648

CCCC(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681324 0.91 LMNA (0.30)
SCHEMBL18427222 0.88 LMNA (0.35)
SCHEMBL18427274 0.88 LMNA (0.35)
SCHEMBL18427238 0.88 LMNA (0.35)
SCHEMBL19148317 0.88 LMNA (0.35)
SCHEMBL18978687 0.88 LMNA (0.35)
SCHEMBL20991725 0.88 LMNA (0.35)
SCHEMBL12530888 0.88 LMNA (0.35)
SCHEMBL20991695 0.88 LMNA (0.35)
SCHEMBL16478907 0.88 LMNA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5275669-A Degreasing glass, metal, plastic and fiber surfaces ALLIEDSIGNAL INC. (US) 1994-01-04 US claimed
WO-2026104414-A1 TOPICAL COMPOSITIONS FOR THE TREATMENT OF ALOPECIA AREATA DERMALIQ THERAPEUTICS GMBH (DE) 2026-05-21 WO disclosed
EP-4687844-A1 TRI-AZOLE ANTIFUNGAL COMPOSITIONS Dermaliq Therapeutics, Inc. (US) 2026-02-11 EP disclosed
US-20250345276-A1 O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES NOVALIQ GMBH (DE) 2025-11-13 US disclosed
EP-4637708-A2 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE Novaliq GmbH (DE) 2025-10-29 EP disclosed
EP-4618949-A1 SEMIFLUORINATED ALKANE ANTIBIOTIC COMBINATION COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS Coffey, Martin (US) 2025-09-24 EP disclosed
US-12397039-B2 Compositions and methods for the treatment of ocular neovascularization NOVALIQ GMBH (DE) 2025-08-26 US disclosed
US-20250161294-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISORDERS JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2025-05-22 US disclosed
WO-2025104294-A1 SEMIFLUORINATED ALKANE SMALL MOLECULE LFA-1 ANTAGONIST COMBINATION COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS BAUSCH + LOMB IRELAND LIMITED (IE) 2025-05-22 WO disclosed
WO-2025093739-A1 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING LIFITEGRAST NOVALIQ GMBH (DE) 2025-05-08 WO disclosed
EP-0850210-A1 PROCESS FOR THE PREPARATION OF HALOGENATED ALKANES AlliedSignal Inc. (US) 1998-07-01 EP disclosed
WO-1997007083-A1 PROCESS FOR THE PREPARATION OF HALOGENATED ALKANES ALLIEDSIGNAL INC. (US) 1997-02-27 WO disclosed
EP-0701634-A1 MULTIPLE SOLVENT CLEANING SYSTEM AlliedSignal Inc. (US) 1996-03-20 EP disclosed
WO-1994028196-A1 MULTIPLE SOLVENT CLEANING SYSTEM ALLIEDSIGNAL INC. (US) 1994-12-08 WO disclosed
US-5298083-A Exposure of substrate to solvent ALLIEDSIGNAL INC. (US) 1994-03-29 US disclosed
US-5275669-A Degreasing glass, metal, plastic and fiber surfaces ALLIEDSIGNAL INC. (US) 1994-01-04 US disclosed
EP-0027059-B1 OPTICAL WAVEGUIDE RAYCHEM CORPORATION (a California corporation) (US) 1986-01-22 EP disclosed
US-4431264-A Fluorosiloxane optical cladding RAYCHEM CORPORATION (US) 1984-02-14 US disclosed
US-4317616-A Fluorosiloxane optical cladding RAYCHEM CORPORATION (US) 1982-03-02 US disclosed
EP-0027059-A1 Optical waveguide RAYCHEM CORPORATION (a California corporation) (US) 1981-04-15 EP disclosed